These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28384546)

  • 1. In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates.
    Baranyai Z; Krátký M; Vosátka R; Szabó E; Senoner Z; Dávid S; Stolaříková J; Vinšová J; Bősze S
    Eur J Med Chem; 2017 Jun; 133():152-173. PubMed ID: 28384546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
    Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
    Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cellular uptake of a new, in silico identified antitubercular candidate by peptide conjugation.
    Horváti K; Bacsa B; Szabó N; Dávid S; Mező G; Grolmusz V; Vértessy B; Hudecz F; Bősze S
    Bioconjug Chem; 2012 May; 23(5):900-7. PubMed ID: 22515329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host cell targeting of novel antimycobacterial 4-aminosalicylic acid derivatives with tuftsin carrier peptides.
    Borbála Horváth L; Krátký M; Pflégr V; Méhes E; Gyulai G; Kohut G; Babiczky Á; Biri-Kovács B; Baranyai Z; Vinšová J; Bősze S
    Eur J Pharm Biopharm; 2022 May; 174():111-130. PubMed ID: 35378278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
    Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
    Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.
    Krátký M; Janďourek O; Baranyai Z; Novotná E; Stolaříková J; Bősze S; Vinšová J
    Eur J Med Chem; 2019 Nov; 181():111578. PubMed ID: 31401536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide conjugates of therapeutically used antitubercular isoniazid-design, synthesis and antimycobacterial effect.
    Horváti K; Mezo G; Szabó N; Hudecz F; Bosze S
    J Pept Sci; 2009 May; 15(5):385-91. PubMed ID: 19319854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
    Paraskevopoulos G; Monteiro S; Vosátka R; Krátký M; Navrátilová L; Trejtnar F; Stolaříková J; Vinšová J
    Bioorg Med Chem; 2017 Feb; 25(4):1524-1532. PubMed ID: 28126437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase.
    Krátký M; Vinšová J; Novotná E; Mandíková J; Wsól V; Trejtnar F; Ulmann V; Stolaříková J; Fernandes S; Bhat S; Liu JO
    Tuberculosis (Edinb); 2012 Sep; 92(5):434-9. PubMed ID: 22765970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity.
    Carneiro SP; Carvalho KV; de Oliveira Aguiar Soares RD; Carneiro CM; de Andrade MHG; Duarte RS; Dos Santos ODH
    Colloids Surf B Biointerfaces; 2019 Mar; 175():306-313. PubMed ID: 30553206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides].
    Waisser K; Kubicová L; Gregor J; Budová J; Andrlová A; Drsata J; Odlerová Z
    Ceska Slov Farm; 1998 Mar; 47(2):84-6. PubMed ID: 9650366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase.
    Krátký M; Vinšová J; Novotná E; Stolaříková J
    Eur J Pharm Sci; 2014 Mar; 53():1-9. PubMed ID: 24333643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oriented development of antituberculotics: salicylanilides.
    Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
    Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains.
    Krátký M; Vinšová J; Stolaříková J
    Molecules; 2012 Oct; 17(11):12812-20. PubMed ID: 23114617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of antitubercular salicylanilides consistent with disruption of the proton gradient via proton shuttling.
    Lee IY; Gruber TD; Samuels A; Yun M; Nam B; Kang M; Crowley K; Winterroth B; Boshoff HI; Barry CE
    Bioorg Med Chem; 2013 Jan; 21(1):114-26. PubMed ID: 23211970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
    Krátký M; Bősze S; Baranyai Z; Szabó I; Stolaříková J; Paraskevopoulos G; Vinšová J
    Bioorg Med Chem; 2015 Feb; 23(4):868-75. PubMed ID: 25593095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of new peptide conjugates of antitubercular drug candidates-Model membrane and in vitro studies.
    Ábrahám Á; Baranyai Z; Gyulai G; Pári E; Horváti K; Bősze S; Kiss É
    Colloids Surf B Biointerfaces; 2016 Nov; 147():106-115. PubMed ID: 27497074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferrin conjugates of antitubercular drug isoniazid: Synthesis and in vitro efficacy.
    Sutar YB; Mali JK; Telvekar VN; Rajmani RS; Singh A
    Eur J Med Chem; 2019 Dec; 183():111713. PubMed ID: 31557610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimycobacterial activity of salicylanilide benzenesulfonates.
    Krátký M; Vinšová J; Rodriguez NG; Stolaříková J
    Molecules; 2012 Jan; 17(1):492-503. PubMed ID: 22222908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
    Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
    Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.